Ceesay Abraham's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Sep 24, 2026
- Accession no.
- 0001193125-26-401017
- Filed
- Sep 24, 2026, 4:05 PM ET
- Trade date
- Sep 23, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $86.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ceesay AbrahamCIK 0001722140 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Common Stock | SSaleDisposed | −1,952 | $39.05 | −$76,230.09 | 457,025 | Direct | |
| Sep 23, 2026 | Common Stock | SSaleDisposed | −215 | $39.86 | −$8,569.94 | 456,810 | Direct | |
| Sep 23, 2026 | Common Stock | SSaleDisposed | −43 | $41.05 | −$1,765.15 | 456,767 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.